New generation bioresorbable scaffold technologies: An update on novel devices and clinical results

D Regazzoli; PP Leone; A Colombo; A Latib

New generation bioresorbable scaffold technologies: An update on novel devices and clinical results

D Regazzoli, PP Leone, A Colombo, A Latib

IRCCS Ospedale San Raffaele

Research output: Contribution to journal › Article › peer-review

Abstract

Bioresorbable scaffolds (BRS) represent a novel horizon in interventional cardiology and may lead to some potential long-term advantages including the restoration of vasomotion, positive remodeling and a reduced incidence of late and very-late scaffold thrombosis (ScT). This technology, introduced to overcome limitations of current metallic drug-eluting stents (DES), is constantly and rapidly evolving with many companies working on bioresorbable devices. The aim of this review is to present an update on the most promising scaffolds that are under development. © Journal of Thoracic Disease.

Original language	English
Pages (from-to)	S979-S985
Journal	Journal of Thoracic Disease
Volume	9
Issue number	2
Publication status	Published - 2017

Access to Document

http://www.scopus.com/inward/record.url?scp=85027986604&partnerID=8YFLogxK

Fingerprint Dive into the research topics of 'New generation bioresorbable scaffold technologies: An update on novel devices and clinical results'. Together they form a unique fingerprint.

Cite this

@article{8062059454634772a6234d0ce1c3c15f,

title = "New generation bioresorbable scaffold technologies: An update on novel devices and clinical results",

abstract = "Bioresorbable scaffolds (BRS) represent a novel horizon in interventional cardiology and may lead to some potential long-term advantages including the restoration of vasomotion, positive remodeling and a reduced incidence of late and very-late scaffold thrombosis (ScT). This technology, introduced to overcome limitations of current metallic drug-eluting stents (DES), is constantly and rapidly evolving with many companies working on bioresorbable devices. The aim of this review is to present an update on the most promising scaffolds that are under development. {\textcopyright} Journal of Thoracic Disease.",

author = "D Regazzoli and PP Leone and A Colombo and A Latib",

year = "2017",

language = "English",

volume = "9",

pages = "S979--S985",

journal = "Journal of Thoracic Disease",

issn = "2072-1439",

publisher = "AME Publishing Company",

number = "2",

}

TY - JOUR

T1 - New generation bioresorbable scaffold technologies: An update on novel devices and clinical results

AU - Regazzoli, D

AU - Leone, PP

AU - Colombo, A

AU - Latib, A

PY - 2017

Y1 - 2017

N2 - Bioresorbable scaffolds (BRS) represent a novel horizon in interventional cardiology and may lead to some potential long-term advantages including the restoration of vasomotion, positive remodeling and a reduced incidence of late and very-late scaffold thrombosis (ScT). This technology, introduced to overcome limitations of current metallic drug-eluting stents (DES), is constantly and rapidly evolving with many companies working on bioresorbable devices. The aim of this review is to present an update on the most promising scaffolds that are under development. © Journal of Thoracic Disease.

AB - Bioresorbable scaffolds (BRS) represent a novel horizon in interventional cardiology and may lead to some potential long-term advantages including the restoration of vasomotion, positive remodeling and a reduced incidence of late and very-late scaffold thrombosis (ScT). This technology, introduced to overcome limitations of current metallic drug-eluting stents (DES), is constantly and rapidly evolving with many companies working on bioresorbable devices. The aim of this review is to present an update on the most promising scaffolds that are under development. © Journal of Thoracic Disease.

M3 - Article

VL - 9

SP - S979-S985

JO - Journal of Thoracic Disease

JF - Journal of Thoracic Disease

SN - 2072-1439

IS - 2

ER -